Lord, Abbett & Co’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.5M | Sell |
84,217
-33,807
| -29% | -$10.2M | 0.08% | 247 |
|
|
2025
Q1 | $39.1M | Buy |
118,024
+69,107
| +141% | +$22.9M | 0.14% | 180 |
|
|
2024
Q4 | $15.1M | Buy |
+48,917
| New | +$15.1M | 0.05% | 355 |
|
|
2024
Q2 | – | Sell |
-97,103
| Closed | -$25.9M | – | 567 |
|
|
2024
Q1 | $25.9M | Buy |
+97,103
| New | +$25.9M | 0.08% | 289 |
|
|
2023
Q3 | – | Sell |
-67,918
| Closed | -$15.7M | – | 560 |
|
|
2023
Q2 | $15.7M | Sell |
67,918
-107
| -0.2% | -$24.7K | 0.05% | 382 |
|
|
2023
Q1 | $16.5M | Sell |
68,025
-110,493
| -62% | -$26.8M | 0.06% | 379 |
|
|
2022
Q4 | $51.8M | Buy |
+178,518
| New | +$51.8M | 0.19% | 158 |
|
|
2018
Q3 | – | Sell |
-92,193
| Closed | -$25.8M | – | 864 |
|
|
2018
Q2 | $25.8M | Buy |
92,193
+31,993
| +53% | +$8.95M | 0.08% | 409 |
|
|
2018
Q1 | $7.03M | Sell |
60,200
-42,042
| -41% | -$4.91M | 0.02% | 671 |
|
|
2017
Q4 | $9.38M | Buy |
+102,242
| New | +$9.38M | 0.03% | 633 |
|